Gene_set,Term,P-value,Adjusted P-value,Old P-value,Old adjusted P-value,Odds Ratio,Combined Score,Genes
TargetScan_microRNA_2017,mmu-miR-669f-5p,1.2665643150804935e-06,0.00016876969498447574,0,0,13.08185053380783,177.64109861206737,TENM1;RPS6KA6;EDA;NRK;PCDH11X;HTR2C;TAB3;MBNL3;HDX
TargetScan_microRNA_2017,mmu-miR-669l,1.2665643150804935e-06,0.00016876969498447574,0,0,13.08185053380783,177.64109861206737,TENM1;RPS6KA6;EDA;NRK;PCDH11X;HTR2C;TAB3;MBNL3;HDX
TargetScan_microRNA_2017,mmu-miR-669a-5p,1.2665643150804935e-06,0.00016876969498447574,0,0,13.08185053380783,177.64109861206737,TENM1;RPS6KA6;EDA;NRK;PCDH11X;HTR2C;TAB3;MBNL3;HDX
TargetScan_microRNA_2017,mmu-miR-669p,1.2665643150804935e-06,0.00016876969498447574,0,0,13.08185053380783,177.64109861206737,TENM1;RPS6KA6;EDA;NRK;PCDH11X;HTR2C;TAB3;MBNL3;HDX
TargetScan_microRNA_2017,mmu-miR-3965,1.365006433779726e-05,0.0014550968584091878,0,0,10.61991341991342,118.96178849985931,TENM1;VSIG1;FTH1;NRK;PCDH11X;TAB3;MBNL3;HDX
TargetScan_microRNA_2017,mmu-miR-3970,6.840444894717253e-05,0.00607659521480716,0,0,9.468335035750766,90.80202126850352,TENM1;RPS6KA6;EDA;NRK;PCDH11X;MBNL3;HDX
GO_Cellular_Component_2025,Ficolin-1-Rich Granule Lumen (GO:1904813),0.0001739791348688915,0.006437227990148986,0,0,33.05210084033614,286.1179957973964,XRCC6;FTH1;HBB
Human_Phenotype_Ontology,Abnormality of transition element cation homeostasis (HP:0011030),0.00019519729229905975,0.00790549033811192,0,0,117.64285714285714,1004.8464355220641,FTH1;HBB
Human_Phenotype_Ontology,Abnormality of iron homeostasis (HP:0011031),0.00014682753480511646,0.00790549033811192,0,0,137.27083333333334,1211.5869525043622,FTH1;HBB
TargetScan_microRNA_2017,mmu-miR-297b-5p,0.00014326666844954525,0.008338257992505479,0,0,7.435171696149844,65.80723883836994,TENM1;RPS6KA6;EDA;PCDH11X;HTR2C;TAB3;MBNL3;HDX
TargetScan_microRNA_2017,mmu-miR-297a,0.00014326666844954525,0.008338257992505479,0,0,7.435171696149844,65.80723883836994,TENM1;RPS6KA6;EDA;PCDH11X;HTR2C;TAB3;MBNL3;HDX
TargetScan_microRNA_2017,mmu-miR-137,0.00016800390046714053,0.008338257992505479,0,0,7.250864699898271,63.02105993215729,TENM1;RPS6KA6;EDA;NRK;HTR2C;TAB3;MBNL3;HDX
TargetScan_microRNA_2017,mmu-miR-21,0.00018772813491569557,0.008338257992505479,0,0,7.969551979121357,68.38286613867845,TENM1;RPS6KA6;VSIG1;NRK;PCDH11X;TAB3;MBNL3
TargetScan_microRNA_2017,mmu-miR-590-5p,0.00018772813491569557,0.008338257992505479,0,0,7.969551979121357,68.38286613867845,TENM1;RPS6KA6;VSIG1;NRK;PCDH11X;TAB3;MBNL3
TargetScan_microRNA_2017,mmu-miR-297c,0.00014326666844954525,0.008338257992505479,0,0,7.435171696149844,65.80723883836994,TENM1;RPS6KA6;EDA;PCDH11X;HTR2C;TAB3;MBNL3;HDX
GO_Cellular_Component_2025,Ficolin-1-Rich Granule (GO:0101002),0.0005628378947440903,0.01041250105276567,0,0,21.906145251396648,163.91314592377438,XRCC6;FTH1;HBB
GO_Cellular_Component_2025,Tertiary Granule Lumen (GO:1904724),0.0010072159470260857,0.012422330013321724,0,0,49.3375,340.45663764351536,FTH1;HBB
TargetScan_microRNA_2017,mmu-miR-687,0.00034746238867611065,0.012671784434974364,0,0,7.154759225922592,56.98661359008423,TENM1;EDA;FTH1;NRK;PCDH11X;TAB3;MBNL3
TargetScan_microRNA_2017,mmu-miR-3074-1-3p,0.00036088832138782045,0.012671784434974364,0,0,7.106843341160684,56.33553501486952,TENM1;RPS6KA6;EDA;VSIG1;PCDH11X;HTR2C;MBNL3
TargetScan_microRNA_2017,hsa-miR-3681,0.0003636235128450326,0.012671784434974364,0,0,7.097330801876256,56.20654144480916,EDA;FTH1;PCDH11X;HTR2C;TAB3;MBNL3;HDX
TargetScan_microRNA_2017,mmu-miR-382,0.0003803912775977295,0.012671784434974364,0,0,7.0407427937915745,55.44099249475019,TENM1;EDA;NRK;PCDH11X;TAB3;MBNL3;HDX
TargetScan_microRNA_2017,hsa-miR-3135,0.0004912023283093059,0.014278027258520764,0,0,6.726475279106858,51.24669075811145,TENM1;RPS6KA6;EDA;GABRA3;DAPK3;TAB3;MBNL3
TargetScan_microRNA_2017,hsa-miR-3171,0.0005089728291029916,0.014278027258520764,0,0,6.683668076109937,50.68302981718064,TENM1;RPS6KA6;NRK;PCDH11X;HTR2C;TAB3;MBNL3
TargetScan_microRNA_2017,mmu-miR-1941-3p,0.0004894533227014081,0.014278027258520764,0,0,6.730783552316613,51.30352281917579,VSIG1;NRK;PCDH11X;HTR2C;TAB3;MBNL3;HDX
TargetScan_microRNA_2017,mmu-miR-219-5p,0.000550580980013883,0.014602182041339689,0,0,7.582107843137255,56.900205131284324,RPS6KA6;EDA;PCDH11X;HTR2C;TAB3;MBNL3
TargetScan_microRNA_2017,mmu-miR-5117,0.0005753204931859915,0.014602182041339689,0,0,6.537684537684537,48.77494003669653,TENM1;RPS6KA6;EDA;VSIG1;NRK;PCDH11X;MBNL3
TargetScan_microRNA_2017,mmu-miR-3086-5p,0.000647638865493008,0.015690523423080603,0,0,7.338748019017433,53.8823892866635,TENM1;EDA;NRK;PCDH11X;MBNL3;HDX
TargetScan_microRNA_2017,mmu-miR-153,0.0007146794831179906,0.016561920195734305,0,0,6.2852716277675045,45.528473701931105,TENM1;RPS6KA6;EDA;PCDH11X;TAB3;HBB;MBNL3
TargetScan_microRNA_2017,mmu-miR-196b,0.000782604904609979,0.016685136566284755,0,0,7.0630733944954125,50.52133465277365,TENM1;RPS6KA6;EDA;NRK;MBNL3;HDX
TargetScan_microRNA_2017,mmu-miR-196a,0.000782604904609979,0.016685136566284755,0,0,7.0630733944954125,50.52133465277365,TENM1;RPS6KA6;EDA;NRK;MBNL3;HDX
TargetScan_microRNA_2017,mmu-miR-1193-5p,0.0008578763336975593,0.016935114291140706,0,0,6.932381667918858,48.94989775013544,TENM1;EDA;PCDH11X;GABRA3;HTR2C;HDX
TargetScan_microRNA_2017,mmu-miR-379,0.0008578763336975593,0.016935114291140706,0,0,6.932381667918858,48.94989775013544,TENM1;EDA;PCDH11X;GABRA3;HTR2C;HDX
TargetScan_microRNA_2017,mmu-miR-490-3p,0.0008999124853479216,0.017130476953230077,0,0,6.025252525252525,42.25637956656161,TENM1;RPS6KA6;EDA;NRK;PCDH11X;HTR2C;TAB3
TargetScan_microRNA_2017,mmu-miR-448-5p,0.0009706016085403489,0.017838988184551933,0,0,5.941721288116272,41.22125271346584,TENM1;EDA;VSIG1;PCDH11X;TAB3;MBNL3;HDX
TargetScan_microRNA_2017,hsa-miR-1307,0.0013189643109048144,0.02341422038867513,0,0,7.608678086619263,50.45244791912391,TENM1;RPS6KA6;VSIG1;PCDH11X;DAPK3
TargetScan_microRNA_2017,mmu-miR-669o-5p,0.0013618026867709737,0.02341422038867513,0,0,6.303645116918845,41.59741342689492,EDA;NRK;PCDH11X;HTR2C;TAB3;MBNL3
TargetScan_microRNA_2017,mmu-miR-151-3p,0.0014824878336986184,0.024028455565820502,0,0,6.193166441136671,40.34249449689837,TENM1;PCDH11X;GABRA3;TAB3;MBNL3;HDX
TargetScan_microRNA_2017,hsa-miR-4473,0.0014876904946943274,0.024028455565820502,0,0,6.188640973630831,40.29133497742584,TENM1;EDA;NRK;GABRA3;TAB3;MBNL3
TargetScan_microRNA_2017,mmu-miR-3962,0.0016046563742355003,0.025155348454927107,0,0,7.263239273289525,46.73782358723035,TENM1;RPS6KA6;VSIG1;MBNL3;HDX
TargetScan_microRNA_2017,hsa-miR-4637,0.0017193150060055026,0.026182711377169512,0,0,6.003944773175542,38.22008767155688,TENM1;RPS6KA6;PCDH11X;TAB3;MBNL3;HDX
GWAS_Catalog_2023,Phosphatidylethanolamine (18:0 18:2) Levels,0.00815244831797589,0.026655229941185053,0,0,145.4191176470588,699.3840834255094,FTH1
GWAS_Catalog_2023,Phosphatidylcholine (17:0 20:4) Levels,0.00815244831797589,0.026655229941185053,0,0,145.4191176470588,699.3840834255094,FTH1
GWAS_Catalog_2023,Fatty Acid(20:4) [M-H]1- Levels,0.00815244831797589,0.026655229941185053,0,0,145.4191176470588,699.3840834255094,FTH1
GWAS_Catalog_2023,Lysophosphatidylcholine (20:3) [Sn2] Levels,0.00815244831797589,0.026655229941185053,0,0,145.4191176470588,699.3840834255094,FTH1
GWAS_Catalog_2023,Blood Cell Traits (Multivariate Analysis),0.0072497264321968475,0.026655229941185053,0,0,166.2016806722689,818.8410349875032,HBB
GWAS_Catalog_2023,Alkenylphosphatidylethanolamine (P-18:1/20:3) (A) Levels,0.006346229024090702,0.026655229941185053,0,0,193.91176470588235,981.1730711297103,FTH1
GWAS_Catalog_2023,Fear Of Minor Pain,0.009955567809358273,0.026655229941185053,0,0,116.32352941176471,536.2076521530324,TENM1
GWAS_Catalog_2023,Follicle Stimulating Hormone Levels,0.006346229024090702,0.026655229941185053,0,0,193.91176470588235,981.1730711297103,RUVBL2
GWAS_Catalog_2023,Lysophosphatidylcholine (20:3) [Sn1] Levels,0.006346229024090702,0.026655229941185053,0,0,193.91176470588235,981.1730711297103,FTH1
GWAS_Catalog_2023,RBC Levels Of 15-HETE,0.005441955542518843,0.026655229941185053,0,0,232.7058823529412,1213.2392995516034,PCDH11X
GWAS_Catalog_2023,Phosphatidylcholine (20:0 20:4) Levels,0.005441955542518843,0.026655229941185053,0,0,232.7058823529412,1213.2392995516034,FTH1
GWAS_Catalog_2023,Alkenylphosphatidylethanolamine (P-16:0/20:3) (A) Levels,0.00815244831797589,0.026655229941185053,0,0,145.4191176470588,699.3840834255094,FTH1
GWAS_Catalog_2023,"Facial Morphology (Factor 21, Depth Of Nasal Alae)",0.006346229024090702,0.026655229941185053,0,0,193.91176470588235,981.1730711297103,HDX
GWAS_Catalog_2023,Alkenylphosphatidylethanolamine (P-18:0/20:3) (A) Levels,0.00815244831797589,0.026655229941185053,0,0,145.4191176470588,699.3840834255094,FTH1
GWAS_Catalog_2023,Cognitive Performance (Attention) (Longitudinal),0.009955567809358273,0.026655229941185053,0,0,116.32352941176471,536.2076521530324,RPS6KA6
GWAS_Catalog_2023,Phosphatidylethanolamine (18:0 20:3) (A) Levels,0.009054395248932704,0.026655229941185053,0,0,129.2549019607843,608.0803294857882,FTH1
GWAS_Catalog_2023,Phosphatidylethanolamine (18:1 18:2) Levels,0.009054395248932704,0.026655229941185053,0,0,129.2549019607843,608.0803294857882,FTH1
GWAS_Catalog_2023,Lysophosphatidylethanolamine 22:4 [M-H]1- Levels,0.009054395248932704,0.026655229941185053,0,0,129.2549019607843,608.0803294857882,FTH1
GWAS_Catalog_2023,Phosphatidylcholine (18:1 20:3) Levels,0.009054395248932704,0.026655229941185053,0,0,129.2549019607843,608.0803294857882,FTH1
GWAS_Catalog_2023,Phosphatidylethanolamine (15-MHDA 18:2) Levels,0.009054395248932704,0.026655229941185053,0,0,129.2549019607843,608.0803294857882,FTH1
GWAS_Catalog_2023,Phosphatidylethanolamine 38:3 [M-H]1- Levels,0.009955567809358273,0.026655229941185053,0,0,116.32352941176471,536.2076521530324,FTH1
GWAS_Catalog_2023,Phosphatidylcholine 36:3 [M+H]1+/Phosphatidylethanolamine 39:3 [M+H]1+/Phosphatidate 41:4 [M+NH4]1+ Levels,0.009955567809358273,0.026655229941185053,0,0,116.32352941176471,536.2076521530324,FTH1
GWAS_Catalog_2023,Severe Malaria,0.005441955542518843,0.026655229941185053,0,0,232.7058823529412,1213.2392995516034,HBB
GWAS_Catalog_2023,Hemolysis Of Donated Blood (Osmotic),0.009955567809358273,0.026655229941185053,0,0,116.32352941176471,536.2076521530324,HBB
GWAS_Catalog_2023,Phosphatidylcholine (38:5) (B) Levels,0.009955567809358273,0.026655229941185053,0,0,116.32352941176471,536.2076521530324,FTH1
GWAS_Catalog_2023,Phosphatidylcholine 35:3 [M+H]1+/Phosphatidylethanolamine 38:3 [M+H]1+/Phosphatidate 40:4 [M+NH4]1+ Levels,0.009955567809358273,0.026655229941185053,0,0,116.32352941176471,536.2076521530324,FTH1
GWAS_Catalog_2023,Phosphatidylcholine (18:0 20:4) Levels,0.009955567809358273,0.026655229941185053,0,0,116.32352941176471,536.2076521530324,FTH1
GWAS_Catalog_2023,Phosphatidylcholine (15:0 20:4) Levels,0.009955567809358273,0.026655229941185053,0,0,116.32352941176471,536.2076521530324,FTH1
GWAS_Catalog_2023,Phosphatidylinositol 36:3 [M-H]1- Levels,0.00815244831797589,0.026655229941185053,0,0,145.4191176470588,699.3840834255094,FTH1
GWAS_Catalog_2023,Human Chorionic Gonadotropin Levels,0.004536905466485801,0.026655229941185053,0,0,290.8970588235294,1569.5380232030402,RUVBL2
GWAS_Catalog_2023,Phosphatidylcholine (16:0 20:4) Levels,0.00815244831797589,0.026655229941185053,0,0,145.4191176470588,699.3840834255094,FTH1
GWAS_Catalog_2023,Primary Tooth Development (Time To First Tooth Eruption),0.010855966587546282,0.027304400811101255,0,0,105.7433155080214,478.28129169349745,EDA
GWAS_Catalog_2023,Lysophosphatidylcholine 20:4 [M+H]1+ Levels,0.010855966587546282,0.027304400811101255,0,0,105.7433155080214,478.28129169349745,FTH1
GWAS_Catalog_2023,Facial Morphology (Segment 1),0.011755592181114586,0.027877547172357447,0,0,96.92647058823529,430.6856209501431,EDA
GWAS_Catalog_2023,Diacylglycerol 38:3 [M+H-H2O]1+ Levels,0.011755592181114586,0.027877547172357447,0,0,96.92647058823529,430.6856209501431,FTH1
Jensen_DISEASES,Intermediate coronary syndrome,0.004536905466485801,0.02791534265369044,0,0,290.8970588235294,1569.5380232030402,TENM1
Jensen_DISEASES,Anisometropia,0.010855966587546282,0.02791534265369044,0,0,105.7433155080214,478.28129169349745,CYLC1
Jensen_DISEASES,Hypohidrosis,0.010855966587546282,0.02791534265369044,0,0,105.7433155080214,478.28129169349745,EDA
Jensen_DISEASES,Spinal stenosis,0.010855966587546282,0.02791534265369044,0,0,105.7433155080214,478.28129169349745,FTH1
Jensen_DISEASES,Carcinoma,0.010562747129945295,0.02791534265369044,0,0,4.19035674470457,19.06789105656568,TENM1;XRCC6;EDA;NRK;PCDH11X;GABRA3;DAPK3;HTR2C;HBB;RPS6KA6;RUVBL2;TAB3;MBNL3;HDX;CYLC1
Jensen_DISEASES,Hypohidrotic ectodermal dysplasia,0.009955567809358273,0.02791534265369044,0,0,116.32352941176471,536.2076521530324,EDA
Jensen_DISEASES,Cornea plana,0.009955567809358273,0.02791534265369044,0,0,116.32352941176471,536.2076521530324,CYLC1
Jensen_DISEASES,Mucopolysaccharidosis II,0.004536905466485801,0.02791534265369044,0,0,290.8970588235294,1569.5380232030402,GABRA3
Jensen_DISEASES,X-linked nonsyndromic deafness,0.00815244831797589,0.02791534265369044,0,0,145.4191176470588,699.3840834255094,RPS6KA6
Jensen_DISEASES,Coffin-Lowry syndrome,0.00815244831797589,0.02791534265369044,0,0,145.4191176470588,699.3840834255094,RPS6KA6
Jensen_DISEASES,Sotos syndrome,0.009054395248932704,0.02791534265369044,0,0,129.2549019607843,608.0803294857882,NRK
Jensen_DISEASES,Complement component 3 deficiency,0.003631078321344661,0.02791534265369044,0,0,387.88235294117646,2179.2105715199455,MBNL3
Jensen_DISEASES,Congenital dyserythropoietic anemia,0.003631078321344661,0.02791534265369044,0,0,387.88235294117646,2179.2105715199455,HBB
Jensen_DISEASES,Delusional disorder,0.00815244831797589,0.02791534265369044,0,0,145.4191176470588,699.3840834255094,HTR2C
Jensen_DISEASES,Cycloplegia,0.00815244831797589,0.02791534265369044,0,0,145.4191176470588,699.3840834255094,CYLC1
Jensen_DISEASES,High pressure neurological syndrome,0.0072497264321968475,0.02791534265369044,0,0,166.2016806722689,818.8410349875032,HTR2C
Jensen_DISEASES,Anodontia,0.0072497264321968475,0.02791534265369044,0,0,166.2016806722689,818.8410349875032,EDA
Jensen_DISEASES,Premature ejaculation,0.0072497264321968475,0.02791534265369044,0,0,166.2016806722689,818.8410349875032,HTR2C
Jensen_DISEASES,Spondylolysis,0.0072497264321968475,0.02791534265369044,0,0,166.2016806722689,818.8410349875032,FTH1
Jensen_DISEASES,Corneal ectasia,0.0072497264321968475,0.02791534265369044,0,0,166.2016806722689,818.8410349875032,CYLC1
Jensen_DISEASES,Acute chest syndrome,0.0072497264321968475,0.02791534265369044,0,0,166.2016806722689,818.8410349875032,HBB
Jensen_DISEASES,Glomerulonephritis,0.006346229024090702,0.02791534265369044,0,0,193.91176470588235,981.1730711297103,FTH1
Jensen_DISEASES,Hypersplenism,0.006346229024090702,0.02791534265369044,0,0,193.91176470588235,981.1730711297103,HBB
Jensen_DISEASES,Lagophthalmos,0.006346229024090702,0.02791534265369044,0,0,193.91176470588235,981.1730711297103,CYLC1
Jensen_DISEASES,Anterior ischemic optic neuropathy,0.005441955542518843,0.02791534265369044,0,0,232.7058823529412,1213.2392995516034,EDA
Jensen_DISEASES,Neuritis,0.004536905466485801,0.02791534265369044,0,0,290.8970588235294,1569.5380232030402,EDA
Jensen_DISEASES,Spondylolisthesis,0.010855966587546282,0.02791534265369044,0,0,105.7433155080214,478.28129169349745,FTH1
Jensen_DISEASES,DNA ligase IV deficiency,0.004536905466485801,0.02791534265369044,0,0,290.8970588235294,1569.5380232030402,XRCC6
Jensen_DISEASES,Myotonic dystrophy type 1,0.011755592181114586,0.029186297828974146,0,0,96.92647058823529,430.6856209501431,MBNL3
TargetScan_microRNA_2017,mmu-miR-1905,0.001997467436288821,0.02942021232622234,0,0,5.817049808429119,36.15805554068681,TENM1;NRK;PCDH11X;TAB3;MBNL3;HDX
TargetScan_microRNA_2017,hsa-miR-219-5p,0.0020975010664098476,0.02942021232622234,0,0,5.757115749525616,35.50418240302016,RPS6KA6;EDA;PCDH11X;HTR2C;TAB3;MBNL3
TargetScan_microRNA_2017,hsa-miR-4782-3p,0.0020975010664098476,0.02942021232622234,0,0,5.757115749525616,35.50418240302016,RPS6KA6;EDA;PCDH11X;HTR2C;TAB3;MBNL3
TargetScan_microRNA_2017,mmu-miR-3098-5p,0.002173279600680176,0.029701487875962402,0,0,5.713881909547739,35.03476929619031,RPS6KA6;NRK;PCDH11X;HTR2C;TAB3;HDX
Jensen_DISEASES,Glucosephosphate dehydrogenase deficiency,0.012654445189632605,0.030370668455118252,0,0,89.46606334841628,390.94403750725644,HBB
TargetScan_microRNA_2017,hsa-miR-3529,0.0024513907410320143,0.03110931583262056,0,0,5.569018404907975,33.47592523101893,TENM1;XRCC6;PCDH11X;GABRA3;HTR2C;MBNL3
TargetScan_microRNA_2017,hsa-miR-379,0.0024513907410320143,0.03110931583262056,0,0,5.569018404907975,33.47592523101893,TENM1;XRCC6;PCDH11X;GABRA3;HTR2C;MBNL3
TargetScan_microRNA_2017,hsa-miR-508-3p,0.0024361054280714403,0.03110931583262056,0,0,5.576474201474201,33.555622971839746,RPS6KA6;EDA;PCDH11X;HTR2C;TAB3;MBNL3
Jensen_DISEASES,Hypermobility syndrome,0.013552526216859663,0.03147683508431922,0,0,83.07142857142857,357.3053592343188,NRK
Jensen_DISEASES,Histoplasmosis,0.015346374761138145,0.03156968522291275,0,0,72.68014705882354,303.57596227204533,CYLC1
Jensen_DISEASES,Fuchs' endothelial dystrophy,0.015346374761138145,0.03156968522291275,0,0,72.68014705882354,303.57596227204533,CYLC1
Jensen_DISEASES,Testicular cancer,0.015346374761138145,0.03156968522291275,0,0,72.68014705882354,303.57596227204533,PCDH11X
Jensen_DISEASES,Generalized anxiety disorder,0.014449835871258561,0.03156968522291275,0,0,77.52941176470588,328.4977170443537,HTR2C
TargetScan_microRNA_2017,mmu-miR-1898,0.0025763409569550242,0.031934644885047166,0,0,5.510024301336574,32.84737688320838,TENM1;RPS6KA6;NRK;TAB3;MBNL3;HDX
TargetScan_microRNA_2017,mmu-miR-875-5p,0.002646141831180399,0.032054399909526195,0,0,6.4401517764746465,38.220063565904766,TENM1;RPS6KA6;EDA;PCDH11X;MBNL3
Jensen_DISEASES,Centronuclear myopathy,0.016242143499566156,0.03248428699913231,0,0,68.40138408304499,281.8236865664798,GABRA3
TargetScan_microRNA_2017,mmu-miR-547,0.002866673505283374,0.03321602126773996,0,0,5.38488994646044,31.526392721217196,TENM1;RPS6KA6;VSIG1;NRK;MBNL3;HDX
TargetScan_microRNA_2017,mmu-miR-101c,0.0028237340277525538,0.03321602126773996,0,0,5.40244630071599,31.71071283104622,TENM1;RPS6KA6;EDA;NRK;TAB3;MBNL3
Jensen_DISEASES,Seasonal affective disorder,0.018924834901583337,0.03397290710809648,0,0,58.13235294117647,230.6273330077522,HTR2C
Jensen_DISEASES,Hypoparathyroidism,0.018924834901583337,0.03397290710809648,0,0,58.13235294117647,230.6273330077522,HBB
Jensen_DISEASES,Astigmatism,0.018924834901583337,0.03397290710809648,0,0,58.13235294117647,230.6273330077522,CYLC1
Jensen_DISEASES,Eating disorder,0.018031372955673676,0.03397290710809648,0,0,61.195046439628484,245.73740456585463,HTR2C
Jensen_DISEASES,Ureteral disease,0.019817529146389613,0.03397290710809648,0,0,55.36134453781513,217.08226325649278,EDA
Jensen_DISEASES,Amblyopia,0.019817529146389613,0.03397290710809648,0,0,55.36134453781513,217.08226325649278,CYLC1
TargetScan_microRNA_2017,mmu-miR-199a-3p,0.0032569048224971773,0.035024145725923744,0,0,5.2381090487238975,29.998535155622562,TENM1;RPS6KA6;VSIG1;PCDH11X;TAB3;HDX
TargetScan_microRNA_2017,hsa-miR-4740-3p,0.003177915886849889,0.035024145725923744,0,0,6.158476089688471,35.420658004423004,TENM1;PCDH11X;GABRA3;HTR2C;TAB3
TargetScan_microRNA_2017,mmu-miR-199b,0.0032569048224971773,0.035024145725923744,0,0,5.2381090487238975,29.998535155622562,TENM1;RPS6KA6;VSIG1;PCDH11X;TAB3;HDX
TargetScan_microRNA_2017,mmu-miR-3073-3p,0.0032855671412686436,0.035024145725923744,0,0,5.228141285466126,29.895641128963,TENM1;RPS6KA6;NRK;PCDH11X;TAB3;MBNL3
TargetScan_microRNA_2017,hsa-miR-1244,0.003402144476862914,0.035555745218979085,0,0,5.188614146060955,29.48870666680616,TENM1;RPS6KA6;EDA;VSIG1;PCDH11X;HBB
Jensen_DISEASES,Malaria,0.022491011797820155,0.03680347385097844,0,0,48.43382352941177,183.78890112300422,HBB
Jensen_DISEASES,Degenerative disc disease,0.022491011797820155,0.03680347385097844,0,0,48.43382352941177,183.78890112300422,FTH1
TargetScan_microRNA_2017,hsa-miR-4636,0.0036380289549332563,0.037289796788065876,0,0,11.236416184971098,63.107232988598874,EDA;FTH1;PCDH11X
TRRUST_Transcription_Factors_2019,POU2F2 human,0.00815244831797589,0.03756957326527226,0,0,145.4191176470588,699.3840834255094,HBB
TRRUST_Transcription_Factors_2019,NFE2 mouse,0.0072497264321968475,0.03756957326527226,0,0,166.2016806722689,818.8410349875032,HBB
TRRUST_Transcription_Factors_2019,NFYB human,0.012654445189632605,0.03756957326527226,0,0,89.46606334841628,390.94403750725644,HBB
TRRUST_Transcription_Factors_2019,NFYC human,0.011755592181114586,0.03756957326527226,0,0,96.92647058823529,430.6856209501431,HBB
TRRUST_Transcription_Factors_2019,NFE2L2 human,0.014449835871258561,0.03756957326527226,0,0,77.52941176470588,328.4977170443537,HBB
Jensen_DISEASES,Personality disorder,0.02515760723107839,0.038539313205056255,0,0,43.04575163398693,158.5200677488063,HTR2C
Jensen_DISEASES,Hemochromatosis,0.02515760723107839,0.038539313205056255,0,0,43.04575163398693,158.5200677488063,HBB
Jensen_DISEASES,Werner syndrome,0.02515760723107839,0.038539313205056255,0,0,43.04575163398693,158.5200677488063,XRCC6
TargetScan_microRNA_2017,mmu-miR-190b,0.004017912327302738,0.03893722309913381,0,0,5.812139814582811,32.065533700353704,TENM1;RPS6KA6;PCDH11X;TAB3;HDX
TargetScan_microRNA_2017,mmu-miR-190,0.004017912327302738,0.03893722309913381,0,0,5.812139814582811,32.065533700353704,TENM1;RPS6KA6;PCDH11X;TAB3;HDX
TargetScan_microRNA_2017,hsa-miR-4445,0.003955153312533218,0.03893722309913381,0,0,5.020368303571429,27.776372016097316,RPS6KA6;EDA;PCDH11X;HTR2C;TAB3;MBNL3
Jensen_DISEASES,Hyperopia,0.026044944747621757,0.039067417121432635,0,0,41.5063025210084,151.41215211756932,CYLC1
TRRUST_Transcription_Factors_2019,NFYA human,0.018031372955673676,0.03906797473729296,0,0,61.195046439628484,245.73740456585463,HBB
Jensen_DISEASES,Endometrial cancer,0.027131594381133488,0.03927152757412437,0,0,8.613957597173146,31.07103075826391,TENM1;PCDH11X
Jensen_DISEASES,obsessive-compulsive disorder,0.027817332031671423,0.03927152757412437,0,0,38.73529411764706,138.75354204698672,HTR2C
Jensen_DISEASES,Sickle cell anemia,0.027817332031671423,0.03927152757412437,0,0,38.73529411764706,138.75354204698672,HBB
Jensen_DISEASES,Disease of mental health,0.02870238302322923,0.03974176110908662,0,0,37.483870967741936,133.09679671450033,CYLC1
TargetScan_microRNA_2017,mmu-miR-877,0.004203722444446986,0.040010429694468636,0,0,4.953417861080485,27.10403680760593,RPS6KA6;EDA;NRK;PCDH11X;HTR2C;TAB3
TRRUST_Transcription_Factors_2019,ATF1 human,0.021600616979868537,0.04011543153404157,0,0,50.54219948849105,193.8310231891269,FTH1
GWAS_Catalog_2023,Glycated Haemoglobin HbA1c Levels Adjusted For BMI,0.018031372955673676,0.04027593068798505,0,0,61.195046439628484,245.73740456585463,HBB
GWAS_Catalog_2023,Immune Reponse To Smallpox (Secreted IFN-alpha),0.018031372955673676,0.04027593068798505,0,0,61.195046439628484,245.73740456585463,TENM1
GWAS_Catalog_2023,Mean Sphered Cell Volume,0.018924834901583337,0.04027593068798505,0,0,58.13235294117647,230.6273330077522,HBB
GWAS_Catalog_2023,Estimated Glomerular Filtration Rate In Diabetes,0.018924834901583337,0.04027593068798505,0,0,58.13235294117647,230.6273330077522,HBB
TargetScan_microRNA_2017,mmu-miR-216a,0.004391803117889507,0.041067211611142226,0,0,4.905737704918033,26.628419826443988,TENM1;XRCC6;PCDH11X;HTR2C;MBNL3;HDX
TargetScan_microRNA_2017,mmu-miR-3101,0.005025736861618035,0.04138752286777973,0,0,5.4960765664011415,29.091740128828544,EDA;VSIG1;GABRA3;HTR2C;HDX
TargetScan_microRNA_2017,hsa-miR-505,0.005047258886314602,0.04138752286777973,0,0,4.756376195536663,25.156045518984346,TENM1;RPS6KA6;EDA;PCDH11X;GABRA3;MBNL3
TargetScan_microRNA_2017,mmu-miR-3087,0.00473618135003908,0.04138752286777973,0,0,4.82427341227126,25.82203965746187,RPS6KA6;FTH1;NRK;GABRA3;TAB3;MBNL3
TargetScan_microRNA_2017,hsa-miR-2909,0.005020763295724743,0.04138752286777973,0,0,4.761968085106383,25.21068431969837,XRCC6;RPS6KA6;EDA;PCDH11X;HTR2C;MBNL3
TargetScan_microRNA_2017,mmu-miR-669k,0.004928853571756777,0.04138752286777973,0,0,4.781633742658836,25.40314104802597,RPS6KA6;VSIG1;PCDH11X;TAB3;MBNL3;HDX
TargetScan_microRNA_2017,mmu-miR-466f,0.004763375045250502,0.04138752286777973,0,0,6.970841738492573,37.271688373910635,TENM1;PCDH11X;HTR2C;MBNL3
TargetScan_microRNA_2017,mmu-miR-202-5p,0.0046482392457316245,0.04138752286777973,0,0,4.844408427876823,26.020610095790907,TENM1;EDA;NRK;PCDH11X;MBNL3;HDX
TargetScan_microRNA_2017,mmu-miR-669h-3p,0.004928853571756777,0.04138752286777973,0,0,4.781633742658836,25.40314104802597,RPS6KA6;VSIG1;PCDH11X;TAB3;MBNL3;HDX
GO_Cellular_Component_2025,Intracellular Membraneless Organelle (GO:0043232),0.004531954479003394,0.04192057893078139,0,0,5.640416590535356,30.439083341733912,TENM1;XRCC6;RPS6KA6;EDA;DAPK3
TRRUST_Transcription_Factors_2019,LEF1 human,0.026044944747621757,0.042323035214885354,0,0,41.5063025210084,151.41215211756932,EDA
TargetScan_microRNA_2017,mmu-miR-3079-5p,0.005329705065466835,0.042525514111530986,0,0,5.415396341463414,28.346672160527916,RPS6KA6;NRK;GABRA3;MBNL3;HDX
TargetScan_microRNA_2017,hsa-miR-3923,0.00539901703970704,0.042525514111530986,0,0,5.397767126490531,28.18464817228333,TENM1;RPS6KA6;EDA;MBNL3;HDX
TargetScan_microRNA_2017,hsa-miR-4684-3p,0.005485678651162825,0.042525514111530986,0,0,4.668495297805642,24.302386648991348,TENM1;EDA;VSIG1;HTR2C;MBNL3;HDX
TargetScan_microRNA_2017,hsa-miR-4506,0.005686234985215181,0.042525514111530986,0,0,4.630964730290456,23.940730503346057,TENM1;VSIG1;NRK;PCDH11X;GABRA3;MBNL3
TargetScan_microRNA_2017,mmu-miR-1194,0.005715329065618467,0.042525514111530986,0,0,4.625647668393782,23.889635694386897,TENM1;EDA;NRK;PCDH11X;TAB3;HDX
TargetScan_microRNA_2017,mmu-miR-1899,0.005743470685757909,0.042525514111530986,0,0,9.498529411764705,49.0094824399919,TENM1;TAB3;MBNL3
TargetScan_microRNA_2017,mmu-miR-871-3p,0.005744534739268726,0.042525514111530986,0,0,4.620341614906832,23.83868193035558,TENM1;EDA;NRK;GABRA3;MBNL3;HDX
TargetScan_microRNA_2017,mmu-miR-496,0.005865511074638934,0.04282626579154181,0,0,5.2857388513126216,27.16164472784285,TENM1;RPS6KA6;VSIG1;PCDH11X;MBNL3
Jensen_DISEASES,Uveitis,0.032234983634976996,0.042979978179969326,0,0,33.19327731092437,114.0090480941061,EDA
Jensen_DISEASES,Tooth agenesis,0.032234983634976996,0.042979978179969326,0,0,33.19327731092437,114.0090480941061,EDA
TargetScan_microRNA_2017,hsa-miR-4327,0.006088507227151286,0.04299781715979078,0,0,4.560102301790281,23.262688575243317,TENM1;RPS6KA6;EDA;PCDH11X;MBNL3;HDX
TargetScan_microRNA_2017,hsa-miR-1296,0.006147478510916613,0.04299781715979078,0,0,5.223059917238252,26.59432354002198,XRCC6;RPS6KA6;EDA;PCDH11X;MBNL3
TargetScan_microRNA_2017,mmu-miR-3096b-3p,0.006211692160044822,0.04299781715979078,0,0,4.539480387162507,23.066561244885754,TENM1;RPS6KA6;VSIG1;PCDH11X;MBNL3;HDX
TargetScan_microRNA_2017,mmu-miR-219-3p,0.006147478510916613,0.04299781715979078,0,0,5.223059917238252,26.59432354002198,TENM1;RPS6KA6;EDA;NRK;PCDH11X
OMIM_Disease,anemia,0.044503771587737696,0.044503771587737696,0,0,23.69267707082833,73.73590744180093,HBB
SynGO_2024,Ligand-Gated IC Activity Involved In Regulation Of Presynaptic Membrane Potential (GO:0099507) BP,0.021600616979868537,0.046244417232247016,0,0,50.54219948849105,193.8310231891269,GABRA3
SynGO_2024,Synapse (GO:0045202) CC,0.02766246245291329,0.046244417232247016,0,0,8.52229020979021,30.57524102896878,RPS6KA6;GABRA3
SynGO_2024,Transmitter-Gated IC Activity Involved In Regulation Of Postsynaptic Membrane Potential (GO:1904315) BP,0.03751114184039173,0.046244417232247016,0,0,28.327116212338595,93.00124457044232,GABRA3
SynGO_2024,Integral Component Of Postsynaptic Specialization Membrane (GO:0099060) CC,0.038387856069805486,0.046244417232247016,0,0,27.65126050420168,90.14349961279008,GABRA3
SynGO_2024,Integral Component Of Presynaptic Active Zone Membrane (GO:0099059) CC,0.046244417232247016,0.046244417232247016,0,0,22.761245674740483,69.96384769416045,GABRA3
Jensen_DISEASES,Keratoconus,0.035755448274853205,0.04680713228708056,0,0,29.782805429864254,99.20809212234464,CYLC1
Jensen_DISEASES,Prader-Willi syndrome,0.036633672781099316,0.04710043643284198,0,0,29.03676470588235,96.01840883326678,HTR2C
Human_Phenotype_Ontology,Hypochromic anemia (HP:0001931),0.013552526216859663,0.04711423256159896,0,0,83.07142857142857,357.3053592343188,HBB
Human_Phenotype_Ontology,Dysphonia (HP:0001618),0.013552526216859663,0.04711423256159896,0,0,83.07142857142857,357.3053592343188,EDA
Human_Phenotype_Ontology,Respiratory difficulties (HP:0002880),0.013552526216859663,0.04711423256159896,0,0,83.07142857142857,357.3053592343188,EDA
Human_Phenotype_Ontology,Hypoplastic nipples (HP:0002557),0.013552526216859663,0.04711423256159896,0,0,83.07142857142857,357.3053592343188,EDA
Human_Phenotype_Ontology,Polycythemia (HP:0001901),0.012654445189632605,0.04711423256159896,0,0,89.46606334841628,390.94403750725644,HBB
Human_Phenotype_Ontology,Premature skin wrinkling (HP:0100678),0.009955567809358273,0.04711423256159896,0,0,116.32352941176471,536.2076521530324,EDA
Human_Phenotype_Ontology,Abnormal hemoglobin (HP:0011902),0.011755592181114586,0.04711423256159896,0,0,96.92647058823529,430.6856209501431,HBB
Human_Phenotype_Ontology,Short chin (HP:0000331),0.010855966587546282,0.04711423256159896,0,0,105.7433155080214,478.28129169349745,EDA
Human_Phenotype_Ontology,Absent eyebrow (HP:0002223),0.009955567809358273,0.04711423256159896,0,0,116.32352941176471,536.2076521530324,EDA
Human_Phenotype_Ontology,Oligodontia (HP:0000677),0.014449835871258561,0.04711423256159896,0,0,77.52941176470588,328.4977170443537,EDA
Human_Phenotype_Ontology,Hypochromic microcytic anemia (HP:0004840),0.006346229024090702,0.04711423256159896,0,0,193.91176470588235,981.1730711297103,HBB
Human_Phenotype_Ontology,Anhidrosis (HP:0000970),0.011755592181114586,0.04711423256159896,0,0,96.92647058823529,430.6856209501431,EDA
Human_Phenotype_Ontology,Increased serum ferritin (HP:0003281),0.014449835871258561,0.04711423256159896,0,0,77.52941176470588,328.4977170443537,FTH1
Human_Phenotype_Ontology,Conical tooth (HP:0000698),0.011755592181114586,0.04711423256159896,0,0,96.92647058823529,430.6856209501431,EDA
Human_Phenotype_Ontology,Hypoparathyroidism (HP:0000829),0.015346374761138145,0.04711423256159896,0,0,72.68014705882354,303.57596227204533,HBB
Human_Phenotype_Ontology,Abnormality of the heme biosynthetic pathway (HP:0010472),0.015346374761138145,0.04711423256159896,0,0,72.68014705882354,303.57596227204533,HBB
Human_Phenotype_Ontology,Hypotrichosis (HP:0001006),0.018031372955673676,0.04711423256159896,0,0,61.195046439628484,245.73740456585463,EDA
Human_Phenotype_Ontology,Abnormality of molar (HP:0011077),0.018031372955673676,0.04711423256159896,0,0,61.195046439628484,245.73740456585463,EDA
Human_Phenotype_Ontology,Abnormality of molar morphology (HP:0011070),0.018031372955673676,0.04711423256159896,0,0,61.195046439628484,245.73740456585463,EDA
Human_Phenotype_Ontology,Absent hair (HP:0002298),0.018031372955673676,0.04711423256159896,0,0,61.195046439628484,245.73740456585463,EDA
Human_Phenotype_Ontology,Depressed nasal bridge (HP:0005280),0.017153898718089533,0.04711423256159896,0,0,11.065610859728507,44.98757071323116,EDA;HBB
Human_Phenotype_Ontology,Abnormality of permanent molar morphology (HP:0011071),0.017137142691885328,0.04711423256159896,0,0,64.59803921568627,262.68838407017057,EDA
Human_Phenotype_Ontology,Concave nail (HP:0001598),0.0072497264321968475,0.04711423256159896,0,0,166.2016806722689,818.8410349875032,EDA
Human_Phenotype_Ontology,Brittle hair (HP:0002299),0.017137142691885328,0.04711423256159896,0,0,64.59803921568627,262.68838407017057,EDA
Human_Phenotype_Ontology,Taurodontia (HP:0000679),0.017137142691885328,0.04711423256159896,0,0,64.59803921568627,262.68838407017057,EDA
Human_Phenotype_Ontology,Soft skin (HP:0000977),0.016242143499566156,0.04711423256159896,0,0,68.40138408304499,281.8236865664798,EDA
Human_Phenotype_Ontology,Abnormality of renal resorption (HP:0011038),0.016242143499566156,0.04711423256159896,0,0,68.40138408304499,281.8236865664798,HBB
Human_Phenotype_Ontology,Abnormality of the dental root (HP:0006486),0.017137142691885328,0.04711423256159896,0,0,64.59803921568627,262.68838407017057,EDA
Human_Phenotype_Ontology,Type I diabetes mellitus (HP:0100651),0.016242143499566156,0.04711423256159896,0,0,68.40138408304499,281.8236865664798,EDA
Human_Phenotype_Ontology,Abnormality of the dental pulp (HP:0006479),0.018924834901583337,0.04790348834463282,0,0,58.13235294117647,230.6273330077522,EDA
GWAS_Catalog_2023,Monobrow,0.0233806413673251,0.04851483083719959,0,0,46.49411764705882,174.62478721486656,EDA
Human_Phenotype_Ontology,Prominent supraorbital ridges (HP:0000336),0.019817529146389613,0.04864302608659268,0,0,55.36134453781513,217.08226325649278,EDA
TRRUST_Transcription_Factors_2019,CREBBP mouse,0.033996730503354146,0.049106388504844875,0,0,31.395866454689983,106.16483736265805,FTH1
Human_Phenotype_Ontology,Microcytic anemia (HP:0001935),0.021600616979868537,0.04923707988171439,0,0,50.54219948849105,193.8310231891269,HBB
Human_Phenotype_Ontology,Hoarse voice (HP:0001609),0.022491011797820155,0.04923707988171439,0,0,48.43382352941177,183.78890112300422,EDA
Human_Phenotype_Ontology,Abnormal gallbladder morphology (HP:0012437),0.022491011797820155,0.04923707988171439,0,0,48.43382352941177,183.78890112300422,HBB
Human_Phenotype_Ontology,Cholelithiasis (HP:0001081),0.02070945630119187,0.04923707988171439,0,0,52.842245989304814,204.87809910831828,HBB
GO_Molecular_Function_2025,Ferroxidase Activity (GO:0004322),0.004536905466485801,0.04934530267066493,0,0,290.8970588235294,1569.5380232030402,FTH1
GO_Molecular_Function_2025,"Oxidoreductase Activity, Acting on Metal Ions, Oxygen as Acceptor (GO:0016724)",0.004536905466485801,0.04934530267066493,0,0,290.8970588235294,1569.5380232030402,FTH1
GO_Molecular_Function_2025,5'-Deoxyribose-5-Phosphate Lyase Activity (GO:0051575),0.005441955542518843,0.04934530267066493,0,0,232.7058823529412,1213.2392995516034,XRCC6
GO_Molecular_Function_2025,Ferric Iron Binding (GO:0008199),0.005441955542518843,0.04934530267066493,0,0,232.7058823529412,1213.2392995516034,FTH1
GO_Molecular_Function_2025,Leucine Zipper Domain Binding (GO:0043522),0.0072497264321968475,0.04934530267066493,0,0,166.2016806722689,818.8410349875032,DAPK3
GO_Molecular_Function_2025,Double-Stranded Telomeric DNA Binding (GO:0003691),0.0072497264321968475,0.04934530267066493,0,0,166.2016806722689,818.8410349875032,XRCC6
GO_Molecular_Function_2025,Benzodiazepine Receptor Activity (GO:0008503),0.00815244831797589,0.04934530267066493,0,0,145.4191176470588,699.3840834255094,GABRA3
GO_Molecular_Function_2025,RNA Polymerase II Core Promoter Sequence-Specific DNA Binding (GO:0000979),0.009955567809358273,0.04934530267066493,0,0,116.32352941176471,536.2076521530324,RUVBL2
GO_Molecular_Function_2025,LRR Domain Binding (GO:0030275),0.010855966587546282,0.04934530267066493,0,0,105.7433155080214,478.28129169349745,DAPK3
GO_Molecular_Function_2025,G Protein-Coupled Serotonin Receptor Activity (GO:0004993),0.010855966587546282,0.04934530267066493,0,0,105.7433155080214,478.28129169349745,HTR2C
GO_Molecular_Function_2025,cAMP Response Element Binding Protein Binding (GO:0008140),0.0072497264321968475,0.04934530267066493,0,0,166.2016806722689,818.8410349875032,DAPK3
Jensen_DISEASES,Thalassemia,0.03926381608396774,0.04959639926395925,0,0,27.006839945280436,87.43334514672786,HBB
Human_Phenotype_Ontology,Sparse eyelashes (HP:0000653),0.0233806413673251,0.04983768291456141,0,0,46.49411764705882,174.62478721486656,EDA
